Clinical investigations on pancreatic cancer focused on the cysteine-rich secreted protein acid SPARC, which confirmed a correlation between Abraxane and SPARC expression [528,529,530,531]. This evidence concerns the gene SPARC and familial pancreatic carcinoma.